Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-19-005056)

Filing Details

Accession Number:: 0001562180-19-005056
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-10-02 16:20:51
Reporting Period:: 2019-09-30

Accepted Time:: 2019-10-02 16:20:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1685071	Dova Pharmaceuticals Inc.	DOVA	Pharmaceutical Preparations (2834)	813858961

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1762572	Jason Hoitt	C/O Dova Pharmaceuticals, Inc. 240 Leigh Farm Road, Suite 245 Durham NC 27707	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-09-30	2,387	$28.00	9,970	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.